Liver Disease and Transplant

California Pacific CURRENTS: The online journal of CPMC Research Institute

cancerous liver cells

In its early stages, liver cancer grows slowly and is hard to detect, but once established usually progresses rapidly. Researchers at CPMC are testing novel combinations of therapies for liver cancer and are pioneering advances in liver transplant.


 

Overview

Clinical researchers in the Liver Disease Management and Transplant Program are leading new investigations into hepatitis B and C disease management, hepatoma, hepatitis and HIV co-infection, nonalcoholic steatohepatitis, hepatorenal syndrome, and the care of liver transplant patients.


Investigators


Maurizio Bonacini, M.D.
Stewart Cooper, M.D.
Timothy Davern, M.D.
Todd Frederick, M.D.
Jennifer Guy, M.D.
Edward (Will) Holt, M.D.
Raphael Merriman, M.D. 
Robert W. Osorio, M.D., F.A.C.S.
Adil (Ed) Wakil, M.D.
Kidist Yimam, M.D.

Clinical Trials at CPMC

Liver disease clinical trials at CPMC

Related Programs at CPMC

Liver Disease and Liver Transplant Program

Ibrahim El-Hefni Liver Biorepository